Cargando…
Clinical manifestations and treatment of mucopolysaccharidosis type I patients in Latin America as compared with the rest of the world
BACKGROUND: Mucopolysaccharidosis I (MPS I) comprises a spectrum of clinical manifestations and is divided into three phenotypes reflecting clinical severity: Hurler, Hurler-Scheie, and Scheie syndromes. There may be important variations in clinical manifestations of this genetic disease in patients...
Autores principales: | Muñoz-Rojas, María Verónica, Bay, Luisa, Sanchez, Luz, van Kuijck, Marcel, Ospina, Sandra, Cabello, Juan Francisco, Martins, Ana Maria |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer Netherlands
2011
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3173625/ https://www.ncbi.nlm.nih.gov/pubmed/21541721 http://dx.doi.org/10.1007/s10545-011-9336-2 |
Ejemplares similares
-
Guidelines for diagnosis and treatment of Hunter Syndrome for clinicians in Latin America
por: Giugliani, Roberto, et al.
Publicado: (2014) -
The impact of laronidase treatment in otolaryngological manifestations of patients with mucopolysaccharidosis()
por: Dualibi, Ana Paula Fiuza Funicello, et al.
Publicado: (2015) -
Short stature as a presenting symptom of attenuated Mucopolysaccharidosis type I: case report and clinical insights
por: Martins, Ana Maria, et al.
Publicado: (2018) -
Latin America and the world economy since 1800 /
Publicado: (1998) -
COVID-19 in Latin America: Symptoms, Morbidities, and Gastrointestinal Manifestations
por: Ashktorab, Hassan, et al.
Publicado: (2021)